Article | May 27, 2020

Standardization And Control - Protecting Your People, Product And Reputation

By David Heaney

SciLog® FD System

“It takes 20 years to build a reputation and five minutes to ruin it”. Wise words from Warren Buffet.

And in biopharmaceutical manufacturing, these words certainly ring true.

Process variation or operator error in downstream processing can have huge consequences for biopharmaceutical manufacturers, CMOs (contract manufacturing organizations) and CDMOs (contract development and manufacturing organizations).

If a batch is lost due to contamination through human error, for instance, a manufacturer may not only suffer significant financial losses but more importantly, there may be a market shortage of life-changing drugs that patients depend on. The subsequent damage to a company’s reputation can be enormous.

To operate effectively and serve their customer bases, biopharmaceutical manufacturers, CMOs and CDMOs, therefore, need consistent, defined outcomes.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: